Chargement de la fiche…
rhumatologie
Dr Stéphane Hilliquin
Praticien hospitalier
Paris 14e Arrondissement (75679)
Revue générale · Pharmacovigilance · Revue / méta-analyse
0Publications
0Vidéos
0Citations de la publi la +
Après la consultation, le Dr Stéphane Hilliquin peut vous remettre une sélection de ressources adaptée à votre pathologie. Vous avez reçu un code ? Saisissez-le →
Ce qu'il est utile d'apporter à votre rendez-vous avec le Dr Stéphane Hilliquin. Cochez au fur et à mesure — la liste vous suit sur toutes les fiches.
Documents / notes
Examens à apporter
Traitement
Pourquoi consulter Dr Stéphane Hilliquin
- Plateau technique de référence
- Praticien-chercheur
- Conseils vidéo gratuits
- Délais de RDV courts dans la région
Tout est calculé à partir des sources publiques (RPPS, PubMed, OpenAlex, OpenStreetMap…) — aucun classement éditorial.
Dernières publications
Publications les plus citées
25 citationsAbility of disease-modifying antirheumatic drugs to prevent or delay rheumatoid arthritis onset: a systematic literature review and meta-analysis2018 · Annals of the rheumatic diseasesPubMed ↗13 citationsImpact of Early Conventional Treatment on Adult Bone and Joints in a Murine Model of X-Linked Hypophosphatemia2020 · Frontiers in cell and developmental biologyPubMed ↗9 citationsA novel therapeutic strategy for skeletal disorders: Proof of concept of gene therapy for X-linked hypophosphatemia2021 · Science advancesPubMed ↗
Diplômes & qualifications
DES
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'Études Spécialisées
CES
DE Docteur en médecine — Capacité / Certificat d'Études Spéciales
Lieu d'exercice
Domaines d'expertise
Revue généralePharmacovigilanceRevue / méta-analyseCase report / sérieJAK inhibiteurs
Transversal
62026Annals of the rheumatic diseases
PubMed ↗EXTL3 dysfunction identified as a driver of aberrant bone development in severe familial ankylosing spondylitis
2026Rheumatology (Oxford, England)
PubMed ↗18F-fluorodeoxyglucose PET/CT uptake characteristics in immune checkpoint inhibitor-induced polymyalgia rheumatica compared to idiopathic polymyalgia rheumatica
2026Autoimmunity reviews
PubMed ↗SpA in animal models: Unraveling the duality of inflammation and bone formation
2024Bone
PubMed ↗The sacroiliac joint: An original and highly sensitive tool to highlight altered bone phenotype in murine models of skeletal disorders
2021Science advances
PubMed ↗A novel therapeutic strategy for skeletal disorders: Proof of concept of gene therapy for X-linked hypophosphatemia
2020Frontiers in cell and developmental biology
PubMed ↗Impact of Early Conventional Treatment on Adult Bone and Joints in a Murine Model of X-Linked Hypophosphatemia
Revue générale
32026RMD open
PubMed ↗Effect of targeted therapies on pulmonary function in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis
2023Clinical and experimental rheumatology
PubMed ↗Changes of anti-citrullinated peptide antibodies titers after biologic treatment in patients with rheumatoid arthritis: a systematic literature review and retrospective study
2018Annals of the rheumatic diseases
PubMed ↗Ability of disease-modifying antirheumatic drugs to prevent or delay rheumatoid arthritis onset: a systematic literature review and meta-analysis
Pharmacovigilance
22026Annals of the rheumatic diseases
PubMed ↗Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case series
2026Clinical rheumatology
PubMed ↗Real-world efficacy and safety profile of four JAK inhibitors in rheumatoid arthritis: a French single-center observational study
Revue / méta-analyse
22026RMD open
PubMed ↗Effect of targeted therapies on pulmonary function in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis
2018Annals of the rheumatic diseases
PubMed ↗Ability of disease-modifying antirheumatic drugs to prevent or delay rheumatoid arthritis onset: a systematic literature review and meta-analysis
Case report / série
12026Annals of the rheumatic diseases
PubMed ↗Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case series
JAK inhibiteurs
12026RMD open
PubMed ↗Successful treatment of multicentric reticulohistiocytosis with JAK inhibitor: a case series
Vraie vie / RWE
12026Clinical rheumatology
PubMed ↗Real-world efficacy and safety profile of four JAK inhibitors in rheumatoid arthritis: a French single-center observational study
Publications HAL
32021Article
A novel therapeutic strategy for skeletal disorders: Proof of concept of gene therapy for X-linked hypophosphatemia
Science Advances
2021Article
AAV liver gene therapy-mediated inhibition of FGF23 signaling as a therapeutic strategy for X-linked hypophosphatemia
Endocrine Abstracts
2018Article
Ability of Disease-Modifying Antirheumatic Drugs to Prevent or Delay Rheumatoid Arthritis Onset: A Systematic Literature Review and Meta-Analysis
Annals of the Rheumatic Diseases
Rhumatologues à proximité
Données issues de l'Annuaire Santé (ANS) — Licence Ouverte 2.0. Enrichissements à partir de sources publiques. Vous êtes le praticien référencé ? Faites corriger ou retirer votre fiche : demande de rectification ou de retrait.